These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7904647)

  • 1. Molecular electrostatic potential of D1 and D2 dopamine agonists.
    Alkorta I; Villar HO
    J Med Chem; 1994 Jan; 37(1):210-3. PubMed ID: 7904647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2-selective agonist.
    MacKenzie RG; Steffey ME; Manelli AM; Pollock NJ; Frail DE
    FEBS Lett; 1993 May; 323(1-2):59-62. PubMed ID: 8098694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic isoquinolines with hexahydrocyclopenta[ij]-isoquinolines as D2-like selective ligands.
    Párraga J; Andujar SA; Rojas S; Gutierrez LJ; El Aouad N; Sanz MJ; Enriz RD; Cabedo N; Cortes D
    Eur J Med Chem; 2016 Oct; 122():27-42. PubMed ID: 27343851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
    Ge H; Zhang Y; Yang Z; Qiang K; Chen C; Sun L; Chen M; Zhang J
    Bioorg Med Chem; 2019 May; 27(10):2100-2111. PubMed ID: 30981605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
    Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.
    Madapa S; Gadhiya S; Kurtzman T; Alberts IL; Ramsey S; Reith M; Harding WW
    Eur J Med Chem; 2017 Jan; 125():255-268. PubMed ID: 27688181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial neural network (ANN) based modelling for D1 like and D2 like dopamine receptor affinity and selectivity.
    Karolidis DA; Agatonovic-Kustrin S; Morton DW
    Med Chem; 2010 Sep; 6(5):259-70. PubMed ID: 20977414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
    Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1387-91. PubMed ID: 8099621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating D1 and D2 agonists with a hydrophobic similarity index.
    Bone RG; Villar HO
    J Mol Graph; 1995 Jun; 13(3):201-8, 197. PubMed ID: 7577847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys.
    Luquin MR; Guillén J; Martínez-Vila E; Laguna J; Martínez-Lage JM
    Eur J Pharmacol; 1994 Mar; 253(3):215-24. PubMed ID: 7911084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors.
    Seeman P; Sunahara RK; Niznik HB
    Synapse; 1994 May; 17(1):62-4. PubMed ID: 8042146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alan Horn Memorial Lecture. Selective probes for characterization of dopamine D1 and D2 receptors.
    Neumeyer JL; Baindur N; Bakthavachalam V; Yuan J; Madras BK; Kula NS; Campbell A; Baldessarini RJ
    Neurochem Int; 1992 Mar; 20 Suppl():63S-68S. PubMed ID: 1365458
    [No Abstract]   [Full Text] [Related]  

  • 18. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
    Prus AJ; Schuck CJ; Rusch KR; Carey LM
    Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of hexahydrocyclopenta[ij]isoquinolines as a new class of dopaminergic agents.
    Párraga J; Galán A; Sanz MJ; Cabedo N; Cortes D
    Eur J Med Chem; 2015 Jan; 90():101-6. PubMed ID: 25461315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.